Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 12452521)

1.

Cognitive Therapy to Prevent Depressive Relapse in Adults.

Vittengl JR, Jarrett RB.

Curr Opin Psychol. 2015 Aug 1;4:26-31.

PMID:
25729758
2.

Telomere shortening in leukocyte subpopulations in depression.

Karabatsiakis A, Kolassa IT, Kolassa S, Rudolph KL, Dietrich DE.

BMC Psychiatry. 2014 Jul 5;14:192. doi: 10.1186/1471-244X-14-192.

3.

Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes.

Hughes CW, Barnes S, Barnes C, Defina LF, Nakonezny P, Emslie GJ.

Ment Health Phys Act. 2013 Jun;6(2). doi: 10.1016/j.mhpa.2013.06.006.

4.

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder.

Keating C, Dawood T, Barton DA, Lambert GW, Tilbrook AJ.

BMC Psychiatry. 2013 Apr 29;13:124. doi: 10.1186/1471-244X-13-124.

5.

Approaches to understanding and addressing treatment-resistant depression: a scoping review.

Jenkins E, Goldner EM.

Depress Res Treat. 2012;2012:469680. doi: 10.1155/2012/469680. Epub 2012 Apr 18.

6.
7.

Disability in late-life major depression: patterns of self-reported task abilities, task habits, and observed task performance.

Rogers JC, Holm MB, Raina KD, Dew MA, Shih MM, Begley A, Houck PR, Mazumdar S, Reynolds CF 3rd.

Psychiatry Res. 2010 Aug 15;178(3):475-9. doi: 10.1016/j.psychres.2009.11.002.

8.

Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.

Kennard BD, Stewart SM, Hughes JL, Jarrett RB, Emslie GJ.

Cogn Behav Pract. 2008 Nov 1;15(4):387-399.

9.

Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression.

Vittengl JR, Clark LA, Jarrett RB.

Behav Res Ther. 2010 Jun;48(6):449-58. doi: 10.1016/j.brat.2010.01.006. Epub 2010 Feb 4.

10.

Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

Benvenuti A, Rucci P, Calugi S, Cassano GB, Miniati M, Frank E.

Int Clin Psychopharmacol. 2010 Mar;25(2):68-74. doi: 10.1097/YIC.0b013e328333ee8e.

11.

Preschool depression: homotypic continuity and course over 24 months.

Luby JL, Si X, Belden AC, Tandon M, Spitznagel E.

Arch Gen Psychiatry. 2009 Aug;66(8):897-905. doi: 10.1001/archgenpsychiatry.2009.97.

12.

Continuation-phase cognitive therapy's effects on remission and recovery from depression.

Vittengl JR, Clark LA, Jarrett RB.

J Consult Clin Psychol. 2009 Apr;77(2):367-71. doi: 10.1037/a0015238.

13.

Psychosocial determinants of recovery in depression.

Fava GA, Visani D.

Dialogues Clin Neurosci. 2008;10(4):461-72. Review.

14.

Towards achieving remission in the treatment of depression.

Mendlewicz J.

Dialogues Clin Neurosci. 2008;10(4):371-5. Review.

15.

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW.

Am J Psychiatry. 2008 Apr;165(4):459-67. doi: 10.1176/appi.ajp.2007.07091453. Epub 2008 Feb 15.

16.

Is remission of depressive symptoms in primary care a realistic goal? A meta-analysis.

Dawson MY, Michalak EE, Waraich P, Anderson JE, Lam RW.

BMC Fam Pract. 2004 Sep 7;5:19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk